FDA tells on­col­o­gy com­pa­nies how to run mul­ti-re­gion­al can­cer tri­als with a US ap­proval in mind

The FDA on Mon­day re­leased new draft guid­ance on con­duct­ing mul­ti-re­gion­al on­col­o­gy tri­als, say­ing its “para­mount con­sid­er­a­tion” is whether the re­sults ap­ply to the in­tend­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER